Clinical Validation of Salivary Test for Endometriosis – Ziwig Biotech
Ziwig Biotech shared a post on LinkedIn about a paper by Sofiane Bendifallah et al. published in NEJM Evidenc։
“Clinical validation of Ziwig Endotest for the diagnosis of endometriosis
The results of a prospective, multicenter study involving nearly 1,000 patients have just been published in NEJM Evidence (October 28, 2025), confirming a diagnostic accuracy of 96.6% for Ziwig Endotest — the first salivary test developed for the diagnosis of endometriosis.
Ziwig Endotest is now available in 37 countries, and already deployed in 80 hospitals in France, with national reimbursement granted under the Fast Track Innovation Scheme (Forfait Innovation) for up to 25,000 patients.
This milestone is a turning point — for the scientific community, healthcare systems, and above all, for the women living with endometriosis.
We extend our deepest thanks to the clinicians, researchers, institutions, and patients who made this possible.
This clinical validation goes beyond one test. It confirms the potential of our technology platform and strengthens our commitment to delivering impactful innovations for women’s health, globally.”
Title: Validation of a Saliva Micro–RNA Signature for Endometriosis
Authors: Sofiane Bendifallah, Horace Roman, Stéphane Suisse, Andrew Spiers, Erick Petit, Léa Delbos, Yohann Dabi, Cyril Touboul, Thomas Dennis, Benjamin Merlot, Eric Sauvanet, Raffaèle Fauvet, Estelle Jamard, Hennetier Clotilde, Perrin Morgane, Benjamin Fedida, Krystel Nyangoh, Vincent Lavoué, Claire-Marie Roger, Nicolas Lucas, Thomas Darnaud, Anne-Sophie Boudy, Ludivine Genre, Pierre Leguevaque, Cherif Akldios, Mikhael Benjoar, Elodie Chantalat, Yann Tanguy Le Gac, Mathieu Poilblanc, Pascal Rousset, Hervé Fernandez, Francois Golfier, Philippe Descamps
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG